News Conference News PCR London Valves 2019 TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X Michael O'Riordan November 22, 2019
News Conference News PCR London Valves 2019 Signal of Impaired Sapien XT Durability in Midterm Follow-up Michael O'Riordan November 20, 2019
News Conference News TCT 2019 Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR Todd Neale September 29, 2019
News Conference News TCT 2019 Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk Michael O'Riordan September 29, 2019
News Conference News TCT 2019 Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA Michael O'Riordan September 28, 2019
News Conference News TCT 2019 Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT Michael O'Riordan September 27, 2019
News Conference News TVT 2019 Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery Michael O'Riordan June 20, 2019
News Conference News TVT 2019 Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR Michael O'Riordan June 19, 2019
News Conference News TVT 2019 Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI Michael O'Riordan June 17, 2019
News Conference News TVT 2019 Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback Shelley Wood June 14, 2019
News Conference News TVT 2019 Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate Shelley Wood June 13, 2019
News Conference News TVT 2019 PCI During or After TAVR No Riskier Than PCI Before Valve Replacement Michael O'Riordan June 13, 2019
News Conference News EuroPCR 2019 Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact Caitlin E. Cox June 07, 2019
News Conference News EuroPCR 2019 Allegra TAVR System Feasible for Treating Degenerated Surgical Valves Michael O'Riordan May 29, 2019
News Conference News EuroPCR 2019 Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE Michael O'Riordan May 24, 2019
News Conference News EuroPCR 2019 TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out Caitlin E. Cox May 24, 2019
News Conference News EuroPCR 2019 TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement Shelley Wood May 23, 2019
News Conference News EuroPCR 2019 Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle Michael O'Riordan May 23, 2019
News Conference News EHRA 2019 Thromboembolic Risks High in Patients With A-fib, Valvular Disease Todd Neale March 25, 2019
News Conference News ACC 2019 TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients Yael L. Maxwell March 17, 2019